Eating Behavior clinical trials

Explore recruiting eating behavior clinical trials.

Recruiting eating behavior studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Eating Behavior trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Identification and clinical relevance of an oxytocin-deficient state: randomized, crossover, placebo-controlled pilot physiopathological study: GLP1 Study.

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Serotonin role on brain circuits involved in food avoidance in anorexia nervosa : Study of Gaze control and multimodal Brain imaging.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity without type 2 diabetes

Germany, Netherlands, Sweden, Poland, Finland, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity and type 2 diabetes mellitus

Netherlands, Czechia, Denmark, Spain, Poland, Germany +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

SEMAFORCRANIO : Multicenter, double-blind, parallel, randomized controlled trial of the efficacy of semaglutide in hypothalamic obesity secondary to craniopharyngioma in children aged 12 to 17 years

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Eating Behavior trials by city

Eating Behavior in Toronto Eating Behavior in Vancouver Eating Behavior in Montreal Eating Behavior in Calgary Eating Behavior in Edmonton Eating Behavior in Ottawa Eating Behavior in Winnipeg Eating Behavior in Quebec City Eating Behavior in Hamilton Eating Behavior in Kitchener Eating Behavior in London Eating Behavior in Halifax Eating Behavior in New York Eating Behavior in Los Angeles Eating Behavior in Chicago Eating Behavior in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease